Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Pottage John C Jr. Director active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 4 filings have been logged. History available since 15 September 2022. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Pottage John C Jr is a declarant linked to Spero Therapeutics, Inc., where he is Director. The record shows 4 filings in total, all within the sampled recent filings, with the transaction nature listed as Attribution and buy and sell amounts of EUR 0 over the period from 2022-09-19 to 2025-06-16.